“Hero Medical's FST platform simplifies triage decisions with greater prognostic value than current methods that utilize basic vital signs, ultimately saving lives,” commented Dallas Huck, MD, MPH, FACMPH, Army Col. (Ret.). This OTA award and $2.16 million in non-dilutive funding affirms the unmet need for Hero Medical's proprietary technology to transform and expedite emergency medical care for military and civilian injuries. Hero Medical, the world's first dynamic triage platform, demonstrates the utility of continuously classifying patient severity to optimize detection of clinical deterioration and provide early intervention. Integrated ambient dictation further enhances data collection for continuous monitoring during patient treatment.
Debbie Kanter, RN, MSN, APRN, founder of Hero Medical, commented: “Hero Medical has leveraged the clinical insights of nurses, physicians, combat medics, and former high-level military physicians to meet unmet needs. What began as a project to develop a faster bleeding control cranial dressing using the patented Hero Skull Cap has evolved into a complete platform solution to provide faster, multimodal and continuous patient monitoring. With this OTA award as a catalyst for development, we are proud to leverage our differentiated AI/ML Technology brings us one step closer to transforming the delivery of critical care.”
Michael Blaivas, MD, MBA, FACEP, FAIUM, Chief Medical Officer, Hero Medical He commented, “Despite the popular belief that a triaged patient is somehow safer than an unknown patient, the reality is that there is no monitoring between triage and full evaluation. This gap can cause patients to deteriorate unrecognized, or for some to go from stable to critical condition. Continued monitoring after triage is critically needed in a variety of settings, from emergency departments to disaster scenes to battlefields.”
The sensing capabilities of a forehead wearable triage sensor with color-coded alert lights (integrated within the headband or within the Hero Skull Cap) and camera-based facial analysis from your phone or tablet combine to create a high-precision platform for personalized triage care.
About Hero Medical
Hero Medical Technologies Inc. is a medical device company dedicated to revolutionizing emergency medicine through innovative wearable technology and AI-powered facial analysis. The adage “a picture speaks a thousand words” has led to the use of facial analysis to personalize and speed up emergency medical care. Triage is not a static one-time assessment and requires continuous reassessment to capture changes in physiological deterioration. Hero Medical's broad vision is to help bridge the gap in health equity and access to healthcare by creating unique, personalized biosignatures of health. Hero Medical's mission to expedite patient care, especially in critical situations such as traumatic brain injury and stroke, has evolved to meet unmet needs in emergency medical care and monitoring. Hero Medical, a winner of Johnson & Johnson's Nursing Quickfire Challenge and the first company in residence at the Mayo Clinic Life Sciences Incubator, plans to change the paradigm of emergency triage. For more information about Hero Medical, please visit www.heromedtech.com.
This initiative is sponsored by the government through the Medical Technology Enterprise Consortium (MTEC) under Miscellaneous Transaction Number W81XWH-15-9-0001.
The Medical Technology Enterprise Consortium is an internationally distributed 501(c)(3) biomedical technology consortium that collaborates with multiple government agencies under a 10-year renewable miscellaneous transaction agreement with the U.S. Army Medical Research and Development Command. The consortium is focused on developing medical solutions that protect, treat and optimize the health and performance of U.S. military and civilian personnel. For more information about MTEC, please visit https://mtec-sc.org/.
Disclaimer: The views and conclusions contained herein are those of the authors and should not necessarily be construed as representing official policy or approval, expressed or implied, of the U.S. government.
media contact
Debbie Canter, Hero Medical Technologies, 1 9044348119, [email protected]https://www.heromedtech.com
Kristin King-Jankiewicz, Hero Medical Technologies; [email protected]https://www.heromedtech.com
Source: Hero Medical Technologies
